Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
2020 · Nature Communications · 282 citations
https://doi.org/10.1038/s41467-020-19943-y
M
Mengyan Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
1.4K
Citations
15
h-index
21
i10-index
Mengyan Zhu is an academic researcher from Jiangsu Cancer Hospital. The author has contributed to research in topics: Immune cells in cancer & COVID-19 Clinical Research Studies & Phagocytosis and Immune Regulation. The author has an h-index of 15, co-authored 75 publications.
ORCID: 0000-0003-2953-8309Papers by this author
worksSex-based clinical and immunological differences in COVID-19
2021 · BMC Infectious Diseases · 215 citations
https://doi.org/10.1186/s12879-021-06313-2
High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
2021 · Frontiers in Oncology · 29 citations
https://doi.org/10.3389/fonc.2021.644575
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
2024 · Blood Cancer Journal · 15 citations
https://doi.org/10.1038/s41408-024-01199-0
The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
2025 · Frontiers in Immunology · 9 citations
https://doi.org/10.3389/fimmu.2024.1474564
Dysregulated Activation of Hippo-YAP1 Signaling Induces Oxidative Stress and Aberrant Development of Intrahepatic Biliary Cells in Biliary Atresia
2024 · Laboratory Investigation · 5 citations
https://doi.org/10.1016/j.labinv.2024.102199
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat